Literature DB >> 3895901

Nonoliguric acute renal failure.

B S Dixon, R J Anderson.   

Abstract

Oliguria has been considered a cardinal feature of acute renal failure. However, many recent reports indicate that acute renal failure usually occurs in the setting of well-maintained urine output. Moreover, the nonoliguric state may accompany acute renal failure due to pre- and post-renal azotemia and a variety of renal parenchymal disorders, as well as acute tubular necrosis. Most studies indicate that nonoliguric forms of acute renal failure are associated with less morbidity and mortality than oliguric acute renal failure. Uncontrolled studies also suggest that volume expansion, potent diuretic agents, and renal vasodilators can convert oliguric to nonoliguric acute tubular necrosis if administered early in the course of acute renal failure. However, prospective studies of early intervention in oliguric patients are needed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895901     DOI: 10.1016/s0272-6386(85)80144-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Serum magnesium in recovering acute renal failure.

Authors:  R Satish; G Gokulnath
Journal:  Indian J Nephrol       Date:  2008-07

Review 2.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Etiology and outcomes of anuria in acute kidney injury: a single center study.

Authors:  Hye Min Choi; Sun Chul Kim; Myung-Gyu Kim; Sang-Kyung Jo; Won Yong Cho; Hyoung Kyu Kim
Journal:  Kidney Res Clin Pract       Date:  2014-11-25

4.  Urine biochemistry assessment in the sequential evaluation of renal function: Time to think outside the box.

Authors:  Alexandre T Maciel; Daniel Vitorio; Eduardo A Osawa
Journal:  Front Med (Lausanne)       Date:  2022-07-26

5.  Adjudication of etiology of acute kidney injury: experience from the TRIBE-AKI multi-center study.

Authors:  Jay L Koyner; Amit X Garg; Heather Thiessen-Philbrook; Steven G Coca; Lloyd G Cantley; Aldo Peixoto; Cary S Passik; Kwangik Hong; Chirag R Parikh
Journal:  BMC Nephrol       Date:  2014-07-04       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.